US Patent Issued to Deciphera Pharmaceuticals on June 3 for "Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea" (Oregon, Massachusetts Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,374, issued on June 3, was assigned to Deciphera Pharmaceuticals LLC (Waltham, Mass.).

"Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea" was invented by Michael D. Kaufman (Waltham, Mass.), Scott Bone (Bend, Ore.), Corey Bloom (Bend, Ore.) and Fred Jordan (Bend, Ore.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are low impurity compositions comprising a compound represented by Formula (I):which are useful in the treatment of disorders related to the activity of the c-KIT and PDGFRAlpha kinases, and oncogenic forms thereof."

The patent was filed on June 28, 2...